Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H ( (HK:2291) ) has issued an announcement.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. held its 2024 annual general meeting on May 22, 2025, where all resolutions were overwhelmingly approved by shareholders. Key resolutions included the approval of the 2024 work report, financial budget for 2025, re-appointment of auditors, and amendments to the company’s articles of association. The meeting’s outcomes reflect strong shareholder support and are likely to positively impact the company’s strategic direction and governance.
More about LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the medical technology industry, focusing on developing and providing advanced medical solutions.
Average Trading Volume: 1,086,696
Technical Sentiment Signal: Buy
For a thorough assessment of 2291 stock, go to TipRanks’ Stock Analysis page.